A new approach to the treatment of allergic nasopharyngitis.
Orally inhaled and nasally exhaled beclomethasone diproprionate (b.d.) under increased nasopharyngeal pressure was found beneficial in ameliorating symptoms of allergic nasopharyngitis. The most spectacular help was obtained by patients suffering from sinus headache. This treatment also was found to avert the flaring up of rhinitis, an occasional "unmasking" effect of orally inhaled b.d.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001507:Beclomethasone / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009304:Nasopharyngitis / Q000150:complications / Q000188:drug therapy*; D010612:Pharyngitis / Q000188:drug therapy*
D001507:Beclomethasone